CN102813813A - 一种具有降血糖功能的天然药食同源原料组成及制备方法 - Google Patents
一种具有降血糖功能的天然药食同源原料组成及制备方法 Download PDFInfo
- Publication number
- CN102813813A CN102813813A CN2012102150521A CN201210215052A CN102813813A CN 102813813 A CN102813813 A CN 102813813A CN 2012102150521 A CN2012102150521 A CN 2012102150521A CN 201210215052 A CN201210215052 A CN 201210215052A CN 102813813 A CN102813813 A CN 102813813A
- Authority
- CN
- China
- Prior art keywords
- raw material
- add
- weight portion
- radix ginseng
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 50
- 210000004369 blood Anatomy 0.000 title claims abstract description 50
- 239000002994 raw material Substances 0.000 title claims abstract description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 47
- 239000008103 glucose Substances 0.000 title abstract description 47
- 230000003247 decreasing effect Effects 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 28
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 28
- 235000008434 ginseng Nutrition 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 241000208340 Araliaceae Species 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 25
- 230000009467 reduction Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 206010013786 Dry skin Diseases 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000007779 soft material Substances 0.000 claims description 10
- 238000000638 solvent extraction Methods 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 24
- 239000003814 drug Substances 0.000 abstract description 15
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 244000302512 Momordica charantia Species 0.000 abstract 1
- 235000009811 Momordica charantia Nutrition 0.000 abstract 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 abstract 1
- 235000018365 Momordica dioica Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 230000000291 postprandial effect Effects 0.000 description 20
- 238000003745 diagnosis Methods 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 238000009535 clinical urine test Methods 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 230000009978 visual deterioration Effects 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 241000219780 Pueraria Species 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 229930185803 charantin Natural products 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- RJKLDOLOCIQYFS-PRTISISMSA-N miroestrol Chemical compound C12=COC3=CC(O)=CC=C3[C@H]2C(C)(C)[C@@H]2[C@@H]([C@H]3O)[C@@]1(O)C(=O)C[C@]3(O)C2 RJKLDOLOCIQYFS-PRTISISMSA-N 0.000 description 1
- CKEZIBBDMDFHQQ-ILKNQKGPSA-N miroestrol Natural products CC1(C)[C@H]2C[C@]3(O)CC(=O)[C@H]([C@@H]2[C@H]3O)C4=COc5ccccc5[C@@H]14 CKEZIBBDMDFHQQ-ILKNQKGPSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210215052.1A CN102813813B (zh) | 2012-06-27 | 2012-06-27 | 一种具有降血糖功能的天然药食同源原料组成及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210215052.1A CN102813813B (zh) | 2012-06-27 | 2012-06-27 | 一种具有降血糖功能的天然药食同源原料组成及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102813813A true CN102813813A (zh) | 2012-12-12 |
CN102813813B CN102813813B (zh) | 2014-05-14 |
Family
ID=47298495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210215052.1A Active CN102813813B (zh) | 2012-06-27 | 2012-06-27 | 一种具有降血糖功能的天然药食同源原料组成及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102813813B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103461588A (zh) * | 2013-09-06 | 2013-12-25 | 北京绿源求证科技发展有限责任公司 | 一种食疗保健减肥茶冲剂 |
CN103977249A (zh) * | 2014-06-10 | 2014-08-13 | 张磊 | 一种辅助延缓糖尿病肾病的中药组合物及制备方法 |
CN104095234A (zh) * | 2014-07-04 | 2014-10-15 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN105433160A (zh) * | 2015-12-03 | 2016-03-30 | 天益食品(徐州)有限公司 | 一种降血糖型牛蒡复合饮料及其制作方法 |
CN107114776A (zh) * | 2017-05-17 | 2017-09-01 | 刘少辉 | 一种降糖菊苣苦瓜片及其制备方法 |
CN107581620A (zh) * | 2017-09-15 | 2018-01-16 | 何静仁 | 一种降血糖苦瓜多肽复合含片及其制备方法 |
CN108159268A (zh) * | 2018-03-26 | 2018-06-15 | 王桂芬 | 一种用于治疗糖尿病的药物组合物 |
CN108434346A (zh) * | 2018-03-05 | 2018-08-24 | 吴俊� | 一种用于调节、辅助降血糖的药膳组合物及其制备方法 |
CN111149957A (zh) * | 2020-01-08 | 2020-05-15 | 孟凡云 | 一种适合于糖尿病患者饮用的饮料及制备方法 |
CN113101342A (zh) * | 2021-04-27 | 2021-07-13 | 吉林省命之元生物科技有限公司 | 一种具有辅助降血糖功能的中药组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361933A (zh) * | 2008-09-28 | 2009-02-11 | 李静 | 一种降糖冲剂的配置方法 |
CN101391092A (zh) * | 2008-10-21 | 2009-03-25 | 陈伙荣 | 治疗糖尿病的中成药及其加工方法 |
CN101658537A (zh) * | 2008-08-27 | 2010-03-03 | 安琪酵母股份有限公司 | 降血糖用酵母复合物 |
-
2012
- 2012-06-27 CN CN201210215052.1A patent/CN102813813B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101658537A (zh) * | 2008-08-27 | 2010-03-03 | 安琪酵母股份有限公司 | 降血糖用酵母复合物 |
CN101361933A (zh) * | 2008-09-28 | 2009-02-11 | 李静 | 一种降糖冲剂的配置方法 |
CN101391092A (zh) * | 2008-10-21 | 2009-03-25 | 陈伙荣 | 治疗糖尿病的中成药及其加工方法 |
Non-Patent Citations (2)
Title |
---|
于智敏: "谈谈糖耐量异常的综合调控", 《糖尿病新世界》 * |
管正学主编: "《保健食品开发生产技术问答》", 31 March 2000 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103461588A (zh) * | 2013-09-06 | 2013-12-25 | 北京绿源求证科技发展有限责任公司 | 一种食疗保健减肥茶冲剂 |
CN103977249A (zh) * | 2014-06-10 | 2014-08-13 | 张磊 | 一种辅助延缓糖尿病肾病的中药组合物及制备方法 |
CN103977249B (zh) * | 2014-06-10 | 2018-08-28 | 张磊 | 一种辅助延缓糖尿病肾病的中药组合物及制备方法 |
CN104095234A (zh) * | 2014-07-04 | 2014-10-15 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN104095234B (zh) * | 2014-07-04 | 2015-10-28 | 凯泽(武汉)健康管理有限公司 | 一种调理脂肪肝的功能性食品 |
CN105433160A (zh) * | 2015-12-03 | 2016-03-30 | 天益食品(徐州)有限公司 | 一种降血糖型牛蒡复合饮料及其制作方法 |
CN107114776A (zh) * | 2017-05-17 | 2017-09-01 | 刘少辉 | 一种降糖菊苣苦瓜片及其制备方法 |
CN107581620A (zh) * | 2017-09-15 | 2018-01-16 | 何静仁 | 一种降血糖苦瓜多肽复合含片及其制备方法 |
CN108434346A (zh) * | 2018-03-05 | 2018-08-24 | 吴俊� | 一种用于调节、辅助降血糖的药膳组合物及其制备方法 |
CN108159268A (zh) * | 2018-03-26 | 2018-06-15 | 王桂芬 | 一种用于治疗糖尿病的药物组合物 |
CN111149957A (zh) * | 2020-01-08 | 2020-05-15 | 孟凡云 | 一种适合于糖尿病患者饮用的饮料及制备方法 |
CN113101342A (zh) * | 2021-04-27 | 2021-07-13 | 吉林省命之元生物科技有限公司 | 一种具有辅助降血糖功能的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102813813B (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813813B (zh) | 一种具有降血糖功能的天然药食同源原料组成及制备方法 | |
CN101708295B (zh) | 一种治疗糖尿病的中药制剂及其制备方法 | |
CN103053748B (zh) | 一种葛根降脂降糖保健茶及其制备方法 | |
CN103041118B (zh) | 一种具有降血糖降血脂作用的组合物 | |
CN101590101A (zh) | 一种治疗ⅱ型糖尿病及其并发症的处方及制备工艺 | |
CN102630790A (zh) | 一种银杏叶苦荞茶及其制备工艺 | |
CN103300188A (zh) | 一种苦荞降糖颗粒茶及其制作方法 | |
CN103637179B (zh) | 一种降血糖、降血脂和改善脂肪肝的食物组合物 | |
CN103768407B (zh) | 一种复方降糖胶囊及其制备方法 | |
CN101467673A (zh) | 一种复方人参保健品及其制备方法 | |
CN101711798A (zh) | 一种用于降血脂、降血糖的制剂 | |
CN109170476A (zh) | 含有菊苣的保健食品 | |
CN101513492A (zh) | 一种治疗糖尿病的中药 | |
CN101773624A (zh) | 一种用于治疗糖尿病的中药组合物及其制备方法 | |
CN102823700A (zh) | 一种复方茯苓黑大蒜夹心巧克力的制备方法 | |
CN106421581A (zh) | 一种用于治疗糖尿病的生物中药内服药及其制备方法 | |
CN103705860B (zh) | 一种治疗婴幼儿黄疸的中药组合物及其制备方法 | |
CN100462085C (zh) | 一种调节血糖、血压和血脂的药品或保健食品片剂及其制备方法 | |
CN102631425B (zh) | 一种治疗血脂异常的蒙药 | |
CN102178718B (zh) | 一种用于治疗糖尿病和防治心脑血管疾病的制剂 | |
CN101564431B (zh) | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN102846882A (zh) | 一种降糖中药组合物 | |
CN105733880A (zh) | 一种以榛子粕为原料酿制的复合榛子酒 | |
CN101732657A (zh) | 一种药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20121212 Assignee: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Assignor: Shaanxi Jinzheng Pharmaceutical Co., Ltd. Contract record no.: 2015610000027 Denomination of invention: Natural medicinal and edible raw material composition for decreasing blood glucose and preparation method thereof Granted publication date: 20140514 License type: Exclusive License Record date: 20150423 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Assignor: Shaanxi Jinzheng Pharmaceutical Co., Ltd. Contract record no.: 2015610000027 Date of cancellation: 20161227 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171206 Address after: 710018 Shaanxi city of Xi'an province caotan Park Economic Development Zone is 3399 Yuan Lu Patentee after: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Address before: 710086 Shaanxi Province, Xi'an City Waterworks Road Weiyang District Sanqiao Industrial Park No. 108 high Lin Patentee before: Shaanxi Jinzheng Pharmaceutical Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Natural medicinal and edible raw material composition for decreasing blood glucose and preparation method thereof Effective date of registration: 20180508 Granted publication date: 20140514 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Registration number: 2018610000062 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190430 Granted publication date: 20140514 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: SHAANXI CENTURY HEALTH PHARMACY CO., LTD. Registration number: 2018610000062 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200602 Address after: 712000 Fenghuang Road North, Changqing Road East, Yangling Demonstration Area, Xianyang City, Shaanxi Province Patentee after: SHAANXI JINZHENG PHARMACEUTICAL Co.,Ltd. Address before: 710018 Shaanxi city of Xi'an province caotan Park Economic Development Zone is 3399 Yuan Lu Patentee before: SHAANXI CENTURY HEALTH PHARMACY Co.,Ltd. |